Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J/Amgen Bundling Dispute Could Lead To Stricter CMS Accounting Rules

Executive Summary

Johnson & Johnson is moving on several fronts to counter Amgen pricing and discount policies it alleges are anti-competitive, and one result could be the Centers for Medicare & Medicaid Services (CMS) requiring more detailed discount reporting in the Medicare arena

You may also be interested in...



Rep. Thomas Teams Up With Insmed To Promote Follow-on Biologics

Former Rep. Bill Thomas continues his crusade for follow-ons and against Amgen in his new role as consultant to Richmond, Va.-based Insmed, which has big plans for follow-on biologics.

Amgen v. Roche: Mircera Battle Continues In Court And At Trade Commission

Roche has agreed to the conditions set by a federal judge for the launch of its anti-anemia drug Mircera (epoetin beta) in the U.S

Amgen v. Roche: Mircera Battle Continues In Court And At Trade Commission

Roche has agreed to the conditions set by a federal judge for the launch of its anti-anemia drug Mircera (epoetin beta) in the U.S

Related Content

UsernamePublicRestriction

Register

PS078529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel